tiprankstipranks
Ionis Pharmaceuticals initiated with an Underperform at Bernstein
The Fly

Ionis Pharmaceuticals initiated with an Underperform at Bernstein

Bernstein analyst William Pickering initiated coverage of Ionis Pharmaceuticals with an Underperform rating and $31 price target. The company’s ASO technology appears to underperform RNAi on knockdown depth and/or dosing frequency, the analyst tells investors in a research note. The firm says Ionis has experienced "quite a few setbacks over the years," and that this trend will continue "until we have strong evidence to the contrary."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on IONS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles